FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157556838> ?p ?o ?g. }

• W3157556838 endingPage "106588" @default.
• W3157556838 startingPage "106588" @default.
• W3157556838 abstract "Rasburicase can markedly and rapidly decrease uric acid (UA) levels, thereby preventing and treating tumor lysis syndrome. However, rasburicase is expensive, especially when used as per the manufacturer's recommended dosage of 0.2 mg/kg/day for up to 5 days. Numerous reports have shown that lower, and even single doses are effective in lowering UA levels but prospective randomized studies comparing low doses have not been performed. To prospectively determine the efficacy and safety of two single low doses of rasburicase in adult patients (pts) with acute leukemia and elevated plasma UA. Eligible pts aged ≥ 18 years old with acute leukemia and UA ≥ 7.5 mg/dL were randomized to receive an initial single dose of rasburicase 1.5 mg (Arm A) or 3 mg (Arm B) on day 1 in an unblinded fashion. All pts received allopurinol 300 mg daily on days 1–6. Twenty-four pts (median age 69 years; 14 males and 10 females) were enrolled in this phase 2 study (12 on each arm). Twenty pts had acute myeloid leukemia while 3 had acute lymphoblastic leukemia, and 1 had acute promyelocytic leukemia. Median initial UA level was 9.8 mg/dL. Eighty-three percent of pts in both arms achieved UA < 7.5 mg/dL by 24 h after therapy. Five pts (21 %; 2 from Arm A and 3 from Arm B) required additional doses of rasburicase. The majority (23/24) of pts achieved UA goals after 1–2 doses of rasburicase. None had worsening renal function. Both doses were well tolerated, and no treatment related adverse events were reported. Single doses of rasburicase (as low as 1.5−3 mg) used in addition to allopurinol were well tolerated and highly efficacious (83 % response rate) in decreasing UA levels within 24 h of administration in adult acute leukemia pts with hyperuricemia." @default.
• W3157556838 created "2021-05-10" @default.
• W3157556838 creator A5030601713 @default.
• W3157556838 creator A5038004259 @default.
• W3157556838 creator A5038660651 @default.
• W3157556838 creator A5039028985 @default.
• W3157556838 creator A5046140518 @default.
• W3157556838 creator A5051165777 @default.
• W3157556838 creator A5060452476 @default.
• W3157556838 creator A5091066647 @default.
• W3157556838 date "2021-08-01" @default.
• W3157556838 modified "2023-09-25" @default.
• W3157556838 title "A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia" @default.
• W3157556838 cites W1966551456 @default.
• W3157556838 cites W1984538669 @default.
• W3157556838 cites W1996155973 @default.
• W3157556838 cites W2000212618 @default.
• W3157556838 cites W2018552952 @default.
• W3157556838 cites W2021768380 @default.
• W3157556838 cites W2028024825 @default.
• W3157556838 cites W2039488099 @default.
• W3157556838 cites W2050994521 @default.
• W3157556838 cites W2059454686 @default.
• W3157556838 cites W2072270671 @default.
• W3157556838 cites W2078170693 @default.
• W3157556838 cites W2081362814 @default.
• W3157556838 cites W2091838920 @default.
• W3157556838 cites W2095026923 @default.
• W3157556838 cites W2095998688 @default.
• W3157556838 cites W2097084508 @default.
• W3157556838 cites W2099571152 @default.
• W3157556838 cites W2119546886 @default.
• W3157556838 cites W2121307284 @default.
• W3157556838 cites W2122479144 @default.
• W3157556838 cites W2134138207 @default.
• W3157556838 cites W2141234027 @default.
• W3157556838 cites W2155237074 @default.
• W3157556838 cites W2162403132 @default.
• W3157556838 cites W2167545521 @default.
• W3157556838 cites W2199498615 @default.
• W3157556838 cites W2533496686 @default.
• W3157556838 cites W2550381339 @default.
• W3157556838 cites W2554310457 @default.
• W3157556838 cites W2579262776 @default.
• W3157556838 cites W2613763252 @default.
• W3157556838 cites W2730749599 @default.
• W3157556838 cites W2752270043 @default.
• W3157556838 cites W2782669282 @default.
• W3157556838 cites W2792373475 @default.
• W3157556838 cites W2807945527 @default.
• W3157556838 cites W2885460705 @default.
• W3157556838 cites W2960052015 @default.
• W3157556838 cites W2987293424 @default.
• W3157556838 cites W2993078089 @default.
• W3157556838 doi "https://doi.org/10.1016/j.leukres.2021.106588" @default.
• W3157556838 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33957371" @default.
• W3157556838 hasPublicationYear "2021" @default.
• W3157556838 type Work @default.
• W3157556838 sameAs 3157556838 @default.
• W3157556838 citedByCount "3" @default.
• W3157556838 countsByYear W31575568382022 @default.
• W3157556838 countsByYear W31575568382023 @default.
• W3157556838 crossrefType "journal-article" @default.
• W3157556838 hasAuthorship W3157556838A5030601713 @default.
• W3157556838 hasAuthorship W3157556838A5038004259 @default.
• W3157556838 hasAuthorship W3157556838A5038660651 @default.
• W3157556838 hasAuthorship W3157556838A5039028985 @default.
• W3157556838 hasAuthorship W3157556838A5046140518 @default.
• W3157556838 hasAuthorship W3157556838A5051165777 @default.
• W3157556838 hasAuthorship W3157556838A5060452476 @default.
• W3157556838 hasAuthorship W3157556838A5091066647 @default.
• W3157556838 hasConcept C104317684 @default.
• W3157556838 hasConcept C126322002 @default.
• W3157556838 hasConcept C141071460 @default.
• W3157556838 hasConcept C185592680 @default.
• W3157556838 hasConcept C2776601000 @default.
• W3157556838 hasConcept C2776694085 @default.
• W3157556838 hasConcept C2776863199 @default.
• W3157556838 hasConcept C2778461978 @default.
• W3157556838 hasConcept C2778939600 @default.
• W3157556838 hasConcept C2779721657 @default.
• W3157556838 hasConcept C2779788671 @default.
• W3157556838 hasConcept C2779881121 @default.
• W3157556838 hasConcept C2780261098 @default.
• W3157556838 hasConcept C2781121885 @default.
• W3157556838 hasConcept C55493867 @default.
• W3157556838 hasConcept C71924100 @default.
• W3157556838 hasConcept C90924648 @default.
• W3157556838 hasConceptScore W3157556838C104317684 @default.
• W3157556838 hasConceptScore W3157556838C126322002 @default.
• W3157556838 hasConceptScore W3157556838C141071460 @default.
• W3157556838 hasConceptScore W3157556838C185592680 @default.
• W3157556838 hasConceptScore W3157556838C2776601000 @default.
• W3157556838 hasConceptScore W3157556838C2776694085 @default.
• W3157556838 hasConceptScore W3157556838C2776863199 @default.
• W3157556838 hasConceptScore W3157556838C2778461978 @default.
• W3157556838 hasConceptScore W3157556838C2778939600 @default.
• W3157556838 hasConceptScore W3157556838C2779721657 @default.

• next